In this study, we investigate Dyn2 expression across various stages of PCA progression, including benign prostate tissue (BN) high-grade prostatic intraepithelial neoplasia (HGPIN), localized PCA and aggressive PCA (CRPC). The gene discussed is DNM2; the disease is neoplasm.